ASX News Health Care Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4% Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced… 2 mins09 July 2024 10:43 (AEDT)